Chindata & SciPlay: Special Committees Review Proposals; FuelCell Energy Miss Forecasts
- June 08th, 2023
- 307 views
Chindata Group Holdings Limited (Nasdaq: CD) has announced the formation of a special committee to review a non-binding proposal from BCPE Bridge Cayman, L.P. and BCPE Stack Holdings, L.P.
The proposal suggests acquiring all outstanding ordinary shares of the company for a cash consideration of US$8.0 per American depositary share (ADS). The board and special committee have not made a decision regarding the company's response.
In pre-market, $CD is currently trading at $7.09, experiencing a gain of $0.15 or 2.16%.
Similarly, SciPlay Corporation (Nasdaq: SCPL) has formed a special committee of independent directors to review a non-binding proposal from Light & Wonder, Inc. (Nasdaq: LNW) on May 18, 2023.
The proposal suggests acquiring the remaining 17% equity interest in SciPlay for $20.00 per share in cash. The board and special committee have not made a decision regarding the proposed transaction.
$SCPL is currently trading at $19.37 in pre-market, up $0.20 or 1.04%.
FuelCell Energy, Inc. (Nasdaq: FCEL) reported a loss of $0.09 per share for the second quarter of fiscal 2023, slightly worse than the consensus estimate of a loss of $0.07 per share.
Despite the loss, the company achieved significant growth in revenue, with Q2 revenue amounting to $38.3 million, more than double that of the same quarter in the previous year.
In pre-market, $FCEL is currently trading at $2.28, reflecting a decline of $0.10 (-4.20%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
Johnson & Johnson, Charles Schwab, Halliburton: Earnings Preview
January 18th, 2026Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026




Member Login